Chafik Alejandro Chacur
Overview
Explore the profile of Chafik Alejandro Chacur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Novella-Navarro M, Ruiz-Esquide V, Lopez-Juanes N, Chacur C, Monjo-Henry I, Nuno L, et al.
Clin Rheumatol
. 2024 Jul;
43(9):2817-2823.
PMID: 39009920
Objectives: To evaluate the survival of different biologic or targeted-synthetic disease-modifying antirheumatic drugs (b/tsDMARD) administered after fulfilling difficult-to-treat rheumatoid arthritis (D2TRA) criteria, and to assess factors related to treatment discontinuation....
2.
Frade-Sosa B, Chacur C, Auge J, Ponce A, Sarmiento-Monroy J, Azuaga A, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296947
Background: this is an exploratory study to evaluate calprotectin serum levels in patients with rheumatic immune-related adverse events (irAEs) induced by immune checkpoint inhibitor (ICI) treatment. Methods: this is a...
3.
Novella-Navarro M, Ruiz-Esquide V, Torres-Ortiz G, Chacur C, Tornero C, Fernandez-Fernandez E, et al.
Clin Exp Rheumatol
. 2022 Nov;
41(5):1114-1119.
PMID: 36377568
Objectives: Multiple failures to biologic or targeted specific disease-modifying anti-rheumatic drugs (b/tsDMARDs) that lead to difficult-to-treat rheumatoid arthritis (D2TRA) may be the result of multi-drug inefficacy or reflect treatment problems...
4.
Novella-Navarro M, Benavent D, Ruiz-Esquide V, Tornero C, Diaz-Almiron M, Chacur C, et al.
Ther Adv Musculoskelet Dis
. 2022 Oct;
14:1759720X221124028.
PMID: 36226311
Background: Despite advances in the treatment of rheumatoid arthritis (RA) and the wide range of therapies available, there is a percentage of patients whose treatment presents a challenge for clinicians...